Literature DB >> 17425334

Interaction of the fibronectin COOH-terminal Fib-2 regions with fibrin: further characterization and localization of the Fib-2-binding sites.

Evgeny Makogonenko1, Kenneth C Ingham, Leonid Medved.   

Abstract

Incorporation of fibronectin into fibrin clots is important for the formation of a provisional matrix that promotes cell adhesion and migration during wound healing. Previous studies revealed that this incorporation occurs through noncovalent interaction between two NH2-terminal Fib-1 regions of fibronectin (one on each chain) and the alphaC-regions of fibrin, and is further reinforced by factor XIIIa-mediated covalent cross-linking of fibronectin to the fibrin matrix. To clarify the role of another pair of fibrin-binding regions, Fib-2, located at the disulfide-linked COOH-terminal ends of fibronectin, we prepared by limited proteolysis a dimeric 140 kDa (Fib-2)2 fragment containing both Fib-2 regions and tested its interaction with recombinant fragments corresponding to the alphaC regions of fibrin(ogen). In both ELISA and surface plasmon resonance (SPR) experiments 140 kDa (Fib-2)2 bound to the immobilized Aalpha221-610 alphaC-fragment. However, the affinity of binding was substantially lower than that for Fib-1. Ligand blotting and ELISA established that the Fib-2 binding site is located in the connector part of the alphaC region including residues Aalpha221-391. Analysis of the SPR-detected binding of fibronectin to the immobilized Aalpha221-610 alphaC-fragment revealed two types of fibronectin-binding sites, one with high affinity and another one with much lower affinity. Competition experiments revealed about 30% inhibition of the Fib-2 mediated binding by increasing concentrations of Fib-1 fragment suggesting partial overlap of the two sets of binding sites. Based on these results and our previous studies we propose a mechanism of interaction of fibronectin with fibrin in which both Fib-1 and Fib-2 play a role.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425334      PMCID: PMC2531210          DOI: 10.1021/bi7001373

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  The amino acid sequence of the alpha-chain of human fibrinogen.

Authors:  R F Doolittle; K W Watt; B A Cottrell; D D Strong; M Riley
Journal:  Nature       Date:  1979-08-09       Impact factor: 49.962

2.  Repeating modular structure of the fibronectin gene: relationship to protein structure and subunit variation.

Authors:  E Odermatt; J W Tamkun; R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

3.  Structural organization of C-terminal parts of fibrinogen A alpha-chains.

Authors:  L V Medved; O V Gorkun; P L Privalov
Journal:  FEBS Lett       Date:  1983-08-22       Impact factor: 4.124

Review 4.  Fibrinogen and fibrin.

Authors:  R F Doolittle
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

5.  Rapid methods for isolation of human plasma fibronectin.

Authors:  S I Miekka; K C Ingham; D Menache
Journal:  Thromb Res       Date:  1982-07-01       Impact factor: 3.944

6.  Affinity chromatography on immobilized fibrin monomer, IV. Two fibrin-binding peptides of a chymotryptic digest of human plasma fibronectin.

Authors:  M Seidl; H Hörmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1983-01

7.  A large cathepsin D-derived fragment from the central part of the fibronectin subunit chains.

Authors:  H Richter; H Hörmann
Journal:  FEBS Lett       Date:  1983-05-08       Impact factor: 4.124

8.  Domains in the fibrinogen molecule.

Authors:  P L Privalov; L V Medved
Journal:  J Mol Biol       Date:  1982-08-25       Impact factor: 5.469

9.  Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma.

Authors:  N E Stathakis; M W Mosesson
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

10.  In vitro formation of disulfide-bonded fibronectin multimers.

Authors:  D F Mosher; R B Johnson
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

View more
  9 in total

Review 1.  Fibronectin Interaction and Enhancement of Growth Factors: Importance for Wound Healing.

Authors:  Katarzyna M Sawicka; Markus Seeliger; Tagai Musaev; Lauren K Macri; Richard A F Clark
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-08-01       Impact factor: 4.730

2.  Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots.

Authors:  Lauren R Schmitt; Rachel Henderson; Alexander Barrett; Zsuzsanna Darula; Aaron Issaian; Angelo D'Alessandro; Nathan Clendenen; Kirk C Hansen
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

3.  Impaired factor XIII activation in patients with congenital afibrinogenemia.

Authors:  Françoise Bridey; Claude Négrier; Cedric Duval; Robert Ariëns; Philippe de Moerloose; Alessandro Casini
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941

4.  Dermatopontin interacts with fibronectin, promotes fibronectin fibril formation, and enhances cell adhesion.

Authors:  Aiko Kato; Osamu Okamoto; Kazushi Ishikawa; Hideaki Sumiyoshi; Noritaka Matsuo; Hidekatsu Yoshioka; Motoyoshi Nomizu; Tatsuo Shimada; Sakuhei Fujiwara
Journal:  J Biol Chem       Date:  2011-03-11       Impact factor: 5.157

5.  The evolution of fibrin-specific targeting strategies.

Authors:  Victoria L Stefanelli; Thomas H Barker
Journal:  J Mater Chem B       Date:  2015-01-13       Impact factor: 6.331

6.  The ultrastructure of fibronectin fibers pulled from a protein monolayer at the air-liquid interface and the mechanism of the sheet-to-fiber transition.

Authors:  Maria Mitsi; Stephan Handschin; Isabel Gerber; Ruth Schwartländer; Enrico Klotzsch; Roger Wepf; Viola Vogel
Journal:  Biomaterials       Date:  2014-10-13       Impact factor: 12.479

7.  Self-assembled fibrinogen-fibronectin hybrid protein nanofibers with medium-sensitive stability.

Authors:  Karl Scheuer; Christian Helbing; Izabela Firkowska-Boden; Klaus D Jandt
Journal:  RSC Adv       Date:  2021-04-16       Impact factor: 3.361

Review 8.  Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective.

Authors:  Fanny Risser; Ivan Urosev; Joanan López-Morales; Yang Sun; Michael A Nash
Journal:  Biophys Rev       Date:  2022-04-06

9.  Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis.

Authors:  Anna Lemańska-Perek; Dorota Krzyżanowska-Gołąb; Małgorzata Pupek; Piotr Klimeczek; Wojciech Witkiewicz; Iwona Kątnik-Prastowska
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.